Pausinystalia mayumbensis
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Pausinystalia mayumbensis |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Pausinystalia Mayumbensis |
| Ipni Id | 759482-1 |
| Plant Name | Pausinystalia Mayumbensis |
| Genus Tax Id | 170025 |
| Disease Name | Indeterminate colitis, Migraine, Atopic eczema, Nausea/vomiting, Insomnia, Multiple sclerosis, Type 2 diabetes mellitus, Metabolic disorder, Obesity, Cannabis use disorder, Knee osteoarthritis, Pain, unspecified, Attention deficit hyperactivity disorder, Functional bladder disorder, Colorectal cancer, Irritable bowel syndrome, Anorexia nervosa, Solid tumour/cancer, Acute myeloid leukaemia, Thyroid cancer, Urinary tract infection, Choreiform disorder, Acute/subacute hepatic failure, Muscular dystrophy, Hypo-thyroidism, General pain disorder, Fungal infection, Inborn lipid metabolism error, Osteoarthritis, Skin and skin-structure infection, Nicotine use disorder, Visual system disease, Diabetes mellitus, type unspecified, Asthma, Rheumatoid arthritis, Acute diabete complication, Chronic pain, Psoriasis, Lupus erythematosus, Chronic kidney disease, Crohn disease, Lower limb mononeuropathy, Alzheimer disease, Hepatic fibrosis/cirrhosis, Bipolar disorder, Schizophrenia, Sickle-cell disorder, Prostate cancer, Dental caries, Cardiovascular disease, Other specified disorders of carbohydrate absorption or transport, Pulmonary hypertension, Cardiac arrest, Cystic fibrosis, coronary artery disease, Disorders of methionine cycle or sulphur amino acid metabolism, Sepsis, Structural developmental anomaly of heart or great vessels, unspecified, Congestive heart failure, Periodontal disease, Tuberculosis of the respiratory system, Hepatocellular carcinoma, NOS, Myocardial infarction, Cataract, Small cell carcinoma of bronchus or lung, Essential hypertension, Duchenne muscular dystrophy, Macular degeneration, COVID-19, Argininosuccinic aciduria, Xerostomia, Galactose-1-phosphate uridyltransferase deficiency, Malaria, Mental/behavioural/neurodevelopmental disorder, Pre-eclampsia, Glioblastoma, primary, NOS, Beta thalassaemia, Melasma, Alcoholic hepatitis, Mature T-cell lymphoma, Allergic/hypersensitivity disorder, Ischaemic heart diseases, unspecified, Neoplasms, Chronic arterial occlusive disease, unspecified, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Other specified malignant neoplasms ofcolon, Hepatocellular carcinoma of liver, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Adenocarcinoma of prostate, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Malignant neoplasms of thymus, Invasive carcinoma of breast, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Malignant neoplasms of adrenal gland, Gliomas of brain |
| Genus Name | Pausinystalia |
| Disease Id | DD72, 8A80, EA80, MD90, 7A00-7A0Z, 8A40, 5A11, 5C50-5D2Z, 5B80-5B81, 6C41, FA01, MG3Z, 6A05, GC50, 2B91, DD91, 6B80, 2A00-2F9Z, 2A60, 2D10, GC08, 8A01, DB91, 8C70, 5A00, 8.00E+43, 1F29-1F2F, 5C52, FA00-FA05, 1F28-1G0Z, 6C4A, 9E1Z, 5A14, CA23, FA20, 5A2Y, MG30, EA90, 4A40, GB61, DD70, 8C11, 8A20, DB93, 6A60, 6A20, 3A51, 2C82, DA08.0, BA00-BE2Z, 5C61.Y, BB01, MC82, CA25, BA8Y-BA8Z, 5C50.B, 1G40-1G41, LA8Z, BD10, DA0C, 1B10, XH4W48, BA41-BA43, 9B10, 2C25.1, BA00, 8C70.1, 9B75, 1D6Y, 5C50.A0, DA02.1, 5C51.40, 1F40-1F45, 6E20-6E8Z, JA24, XH0MB1, 3A50.2, ED60.1, DB94.1, 2A90, 4A80-4A8Z, BA6Z, 2, BD4Z, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, 2C15, 2C12.01, 1F54, 2B72.0, 2D60.0, 2A81, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, 2B90.Y, 2C12.02, 2B70, 2C94.2, 1D82, 2C82.0, 2B72, 2C25.0, 2C76.Z, 2C27, 2C61, 1C62, 2A00.00, XH6153, 2C80.2, 2D11, 2A00.0 |
| Family Name | Rubiaceae |
| Family Tax Id | 24966 |
- 1. (+)-Stephacidin A (PubChem CID: 16127922)
- 2. (1r)-3,5,5-Trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-Tetramethyl-18-[(1r)-2,6,6-Trimethylcyclohex-2-En-1-Yl]octadeca-3,5,7,9,11,13,15,17-Octaen-1-Ynyl]cyclohex-3-En-1-Ol (PubChem CID: 101289802)
- 3. (1r,2r)-2-[(1e,3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15-Octaen-17-Ynyl]-1,3,3-Trimethylcyclohexane-1,2-Diol (PubChem CID: 163014206)
- 4. (1s,3ar,3bs,5ar,6r,8as,8bs)-3a,5a-Dimethyl-6-[(E,2r,5s)-5-Methylhept-3-En-2-Yl]-1,2,3,3b,4,5,6,7,8,8a,8b,9-Dodecahydroindeno[5,4-E]inden-1-Ol (PubChem CID: 163076709)
- 5. (2r)-2-[(2s,5r,9s)-2-[(S)-[(2r,5r)-5-[(1s,3r,5s)-1-[(2r,5r)-5-[(2r,3e,5e)-6-[(2r,3r,5s)-5-[(2r,3r,4r)-2-Hexadecanoyloxy-3-Hydroxy-4-Methyloxan-2-Yl]-3-Hydroxyoxolan-2-Yl]-2,4-Dimethylhexa-3,5-Dienyl]-5-Methyloxolan-2-Yl]-5-Methyl-2,8-Dioxabicyclo[3.2.1]octan-3-Yl]-2-Methyl-4-Oxooxolan-2-Yl]-Hydroxymethyl]-1,10-Dioxaspiro[4.5]decan-9-Yl]propanoic Acid (PubChem CID: 163101767)
- 6. (2r)-3-[(2s,6r,8r,11r)-2-[(E,2r)-4-[(2s,2'r,4r,4ar,6r,8as)-2-[(1s,3s)-1,3-Dihydroxy-3-[(2s,3r,6s)-3-Methyl-1,7-Dioxaspiro[5.5]undecan-2-Yl]propyl]-4-Hydroxy-3-Methylidenespiro[4a,7,8,8a-Tetrahydro-4h-Pyrano[3,2-B]pyran-6,5'-Oxolane]-2'-Yl]but-3-En-2-Yl]-11-Hydroxy-4-Methyl-1,7-Dioxaspiro[5.5]undec-4-En-8-Yl]-2-Hydroxy-2-Methylpropanoic Acid (PubChem CID: 163088763)
- 7. (2s,3s,4s)-4-[(2e,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916711)
- 8. (2s,3s,4s)-4-[(2z,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916712)
- 9. (2z,4e,6e,8e,10e,12e,14e,16e)-3-Hydroxy-19-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-1-[(1r,4s)-4-Hydroxy-1,2,2-Trimethylcyclopentyl]-4,8,13,17-Tetramethylnonadeca-2,4,6,8,10,12,14,16-Octaen-18-Yn-1-One (PubChem CID: 162912290)
- 10. (3r,3'r)-3'-(3-Hydroxyphenyl)-4-Methylspiro[1h-1,4-Benzodiazepine-3,2'-Oxirane]-2,5-Dione (PubChem CID: 92278353)
- 11. (3r,5s)-5-[(1r,4s,6r,7s,9r,10e,12r,17r,19r,20s,29s,32s)-9,32-Dihydroxy-6,10,13,19,20,32-Hexamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 162927161)
- 12. (3r,5s)-5-[(1s,4s,6s,7r,9r,10e,12s,17r,20r,29s,32s)-9,32-Dihydroxy-6,10,13,20,32-Pentamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 163190285)
- 13. (3s,8as)-3-[[(3r)-7,7-Dimethyl-3-(2-Methylbut-3-En-2-Yl)-2-Oxo-1h-Pyrano[2,3-G]indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 16127840)
- 14. (3s,8as)-3-[[2-(2,2-Dimethylbut-3-Enyl)-1h-Indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 163091236)
- 15. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 23428074)
- 16. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 162865461)
- 17. (5z)-5-((2e,4e,6e,8e)-11-((4r)-4-Hydroxy-2,6,6-Trimethyl-1-Cyclohexen-1-Yl)-2,9-Dimethyl-2,4,6,8-Undecatetraen-10-Yn-1-Ylidene)-3-((1e)-2-((1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo(4.1.0)hept-1-Yl)ethenyl)-2(5h)-Furanone (PubChem CID: 134741793)
- 18. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1r,2r,4s)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162883665)
- 19. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]ethenyl]furan-2-One (PubChem CID: 162880763)
- 20. (5z)-5-[(2e,4e,6e,8e)-11-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-2,9-Dimethylundeca-2,4,6,8-Tetraen-10-Ynylidene]-3-[(E)-2-[(1s,2s,4r)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162896470)
- 21. 11,11-Dihydroxysaxitoxin (PubChem CID: 102411284)
- 22. 11beta-Hydroxy-N21-Sulfocarbamoylsaxitoxin (PubChem CID: 136045808)
- 23. 19'-Hexanoyloxyisomytiloxanthin (PubChem CID: 16061209)
- 24. 3,3'-Methylenebis(Tyrosine) (PubChem CID: 3082144)
- 25. 7-Dehydrocholesterol (PubChem CID: 439423)
- 26. [(2s,3r,4s,5r,6s)-6-[5,7-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxochromen-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methyl (4r)-4-(2-Hydroxypropan-2-Yl)cyclohexene-1-Carboxylate (PubChem CID: 162849269)
- 27. Alloxanthin (PubChem CID: 6443740)
- 28. Amarouciaxanthin B/sidnyaxanthin (PubChem CID: 16061221)
- 29. Anandamide (PubChem CID: 5281969)
- 30. Aspermytin A (PubChem CID: 9993091)
- 31. Azaspiracid-3 (PubChem CID: 131842452)
- 32. Beta-Carotene (PubChem CID: 5280489)
- 33. Betaine (PubChem CID: 247)
- 34. Cid 101396440 (PubChem CID: 101396440)
- 35. Cid 154735200 (PubChem CID: 154735200)
- 36. Cid 162860366 (PubChem CID: 162860366)
- 37. Cid 162883225 (PubChem CID: 162883225)
- 38. Cid 162887352 (PubChem CID: 162887352)
- 39. Cid 162913940 (PubChem CID: 162913940)
- 40. Cid 162985394 (PubChem CID: 162985394)
- 41. Cid 162999788 (PubChem CID: 162999788)
- 42. Cid 163014543 (PubChem CID: 163014543)
- 43. Cid 163032184 (PubChem CID: 163032184)
- 44. Cid 163076592 (PubChem CID: 163076592)
- 45. Cid 17753955 (PubChem CID: 17753955)
- 46. Cid 23428237 (PubChem CID: 23428237)
- 47. Corynanthine (PubChem CID: 92766)
- 48. Dihydrocorynantheine (PubChem CID: 3039336)
- 49. Domoic Acid C5'-Diastereomer (PubChem CID: 5311075)
- 50. Ergosterol (PubChem CID: 444679)
- 51. Halocynthiaxanthin (PubChem CID: 11966451)
- 52. Hexadecanoic Acid Propylamide (PubChem CID: 10379895)
- 53. Himeic Acid A (PubChem CID: 11774903)
- 54. Himeic Acid B (PubChem CID: 21579676)
- 55. Himeic Acid C (PubChem CID: 21777983)
- 56. Isodomoic Acid F (PubChem CID: 101790920)
- 57. Mytiloxanthin (PubChem CID: 11365423)
- 58. N,n,n-Trimethylglycinium (PubChem CID: 248)
- 59. Notoamide A (PubChem CID: 16128040)
- 60. Notoamide B (PubChem CID: 16127923)
- 61. Notoamide D (PubChem CID: 16127841)
- 62. Notoamide F (PubChem CID: 25180710)
- 63. Notoamide G (PubChem CID: 25180707)
- 64. Notoamide H (PubChem CID: 25180895)
- 65. Notoamide I (PubChem CID: 25180708)
- 66. Notoamide J (PubChem CID: 25180709)
- 67. Notoamide K (PubChem CID: 25180896)
- 68. Notoamide O (PubChem CID: 102043608)
- 69. Notoamide P (PubChem CID: 46919486)
- 70. Notoamide Q (PubChem CID: 46919487)
- 71. Notoamide R (PubChem CID: 46919488)
- 72. Nv766twa77 (PubChem CID: 102146782)
- 73. Pectenol A/(Pectenol) (PubChem CID: 16061215)
- 74. Sclerotiamide (PubChem CID: 10647785)
- 1. Alzheimer's Disease 1
- 2. Arthritis, Rheumatoid
- 3. Asthma
- 4. Cardiovascular Diseases
- 5. Cataract
- 6. Celiac Disease
- 7. Coronary Artery Disease
- 8. Crohn Disease
- 9. Cystic Fibrosis
- 10. Dental Caries
- 11. Diabetes Mellitus
- 12. Muscular Dystrophies
- 13. Myocardial Infarction
- 14. Obesity
- 15. Pre-Eclampsia
- 16. Psoriasis
- 17. Urinary Tract Infections
Not listed in any formulations.